This inventor holds 1 USPTO granted patent. Top assignee: Nextbiomedical Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Dae Sung Lee and His Work in Medical Embolization
Introduction
Dae Sung Lee is an inventor based in Incheon, South Korea. His work includes an invention concerning embolization hydrogels designed for use in blood vessels.
Latest Patents
Lee is associated with one patent, titled “Embolization Hydrogel Having Controllable Degradation Time, and Preparation Method Therefor.” The invention describes an amorphous, spherical embolization hydrogel whose degradation time can be precisely controlled in blood vessels, along with a method for preparing it. The patent record lists 1 patent.
Career Highlights
Lee is associated with Nextbiomedical Co., Ltd. His patent work focuses on a medical material intended to support controlled degradation in vascular embolization applications.
Collaborations
Lee’s listed coworkers include Don Haeng Lee and Eun Hye Lee.
Conclusion
Dae Sung Lee’s documented invention centers on an embolization hydrogel with controllable degradation time, reflecting his work in medical technology at Nextbiomedical Co., Ltd.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile